146 related articles for article (PubMed ID: 2435902)
1. Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects.
Atwal KS; O'Reilly BC; Ruby EP; Turk CF; Aberg G; Asaad MM; Bergey JL; Moreland S; Powell JR
J Med Chem; 1987 Apr; 30(4):627-35. PubMed ID: 2435902
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
Hefti F; Clozel JP; Osterrieder W
Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
Shanklin JR; Johnson CP; Proakis AG; Barrett RJ
J Med Chem; 1991 Oct; 34(10):3011-22. PubMed ID: 1920352
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.
Renneberg D; Hubler F; Rey M; Hess P; Delahaye S; Gatfield J; Iglarz M; Hilpert K
Bioorg Med Chem Lett; 2015 Sep; 25(18):3941-6. PubMed ID: 26231163
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.
Atwal KS; Swanson BN; Unger SE; Floyd DM; Moreland S; Hedberg A; O'Reilly BC
J Med Chem; 1991 Feb; 34(2):806-11. PubMed ID: 1995904
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
[TBL] [Abstract][Full Text] [Related]
7. Flavones. 1. Synthesis and antihypertensive activity of (3-phenylflavonoxy)propanolamines without beta-adrenoceptor antagonism.
Wu ES; Cole TE; Davidson TA; Blosser JC; Borrelli AR; Kinsolving CR; Milgate TE; Parker RB
J Med Chem; 1987 May; 30(5):788-92. PubMed ID: 2883317
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent.
Yamamoto N; Nomura M; Okubo K; Maeda K; Goto T
J Cardiovasc Pharmacol; 1999 Apr; 33(4):587-94. PubMed ID: 10218729
[TBL] [Abstract][Full Text] [Related]
10. Novel 2-amino-1,4-dihydropyridine calcium antagonists. I. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having nitroxy-alkoxycarbonyl groups at 3- and/or 5-position.
Kobayashi T; Inoue T; Kita Z; Yoshiya H; Nishino S; Oizumi K; Kimura T
Chem Pharm Bull (Tokyo); 1995 May; 43(5):788-96. PubMed ID: 7553966
[TBL] [Abstract][Full Text] [Related]
11. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
Kvam FI; Ofstad J; Iversen BM
Am J Physiol; 1998 Oct; 275(4):F576-84. PubMed ID: 9755129
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Evaluation of New Combined α/β-Adrenergic Blockers.
Némethy A; Vavrinec P; Vavrincová-Yaghi D; Čepcová D; Mišúth S; Král'ová E; Čižmáriková R; Račanská E
Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28480585
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and vasorelaxing activities of synthetic xanthone derivatives.
Wang LW; Kang JJ; Chen IJ; Teng CM; Lin CN
Bioorg Med Chem; 2002 Mar; 10(3):567-72. PubMed ID: 11814844
[TBL] [Abstract][Full Text] [Related]
14. Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.
Kobayashi T; Inoue T; Nishino S; Fujihara Y; Oizumi K; Kimura T
Chem Pharm Bull (Tokyo); 1995 May; 43(5):797-817. PubMed ID: 7553967
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and hypotensive properties of substituted 2-aminotetralins.
Repke DB; Clark RD; Kluge AF; Muchowski JM; Strosberg AM; Lee CH; Whiting RL
J Pharm Sci; 1985 Jan; 74(1):37-9. PubMed ID: 3981415
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive aminotetralins related to labetalol and medroxalol.
Clark RD; Caroon JM; Repke DB; Strosberg AM; Whiting RL; Brown CM
J Pharm Sci; 1986 Jan; 75(1):80-2. PubMed ID: 3007731
[TBL] [Abstract][Full Text] [Related]
17. Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents.
Das J; Floyd DM; Kimball SD; Duff KJ; Lago MW; Krapcho J; White RE; Ridgewell RE; Obermeier MT; Moreland S
J Med Chem; 1992 Jul; 35(14):2610-7. PubMed ID: 1635059
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of halogen-substituted 1,5-benzothiazepine derivatives and their vasodilating and hypotensive activities.
Inoue H; Konda M; Hashiyama T; Otsuka H; Takahashi K; Gaino M; Date T; Aoe K; Takeda M; Murata S
J Med Chem; 1991 Feb; 34(2):675-87. PubMed ID: 1995892
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of 1-alkyl-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents.
Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
Chem Pharm Bull (Tokyo); 2011; 59(11):1376-85. PubMed ID: 22041074
[TBL] [Abstract][Full Text] [Related]
20. Flavones. 2. Synthesis and structure-activity relationship of flavodilol and its analogues, a novel class of antihypertensive agents with catecholamine depleting properties.
Wu ES; Cole TE; Davidson TA; Dailey MA; Doring KG; Fedorchuk M; Loch JT; Thomas TL; Blosser JC; Borrelli AR
J Med Chem; 1989 Jan; 32(1):183-92. PubMed ID: 2909730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
